Disability or Death: A Focused Review of Informed Consent in Pediatric Neurosurgery

被引:2
|
作者
Shlobin, Nathan A. [1 ,2 ]
Kolcun, John Paul G. [3 ]
Leland, Brian D. [5 ,6 ]
Ackerman, Laurie L. [3 ,4 ]
Lam, Sandi K. [1 ,2 ]
Raskin, Jeffrey S. [1 ,2 ,7 ]
机构
[1] Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL USA
[2] Ann & Robert H Lurie Childrens Hosp, Div Pediat Neurosurg, Chicago, IL USA
[3] Rush Univ, Dept Neurol Surg, Chicago, IL USA
[4] Indiana Univ Sch Med, Riley Hosp Children, Dept Neurol Surg, Sect Pediat Neurosurg, Indianapolis, IN USA
[5] Indiana Univ Sch Med, Riley Hosp Children, Dept Pediat, Div Pediat Crit Care Med, Indianapolis, IN USA
[6] Indiana Univ Hlth, Charles Warren Fairbanks Ctr Med Eth, Indianapolis, IN USA
[7] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp, Dept Neurosurg, Div Pediat Neurosurg,Feinberg Sch Med, 225 E Chicago Ave,Box 28, Chicago, IL 60611 USA
关键词
QUALITY-OF-LIFE; SPINA-BIFIDA; BRAIN-TUMORS; SEXUAL FUNCTION; YOUNG-ADULTS; GLOBAL NEUROSURGERY; PATIENT EDUCATION; CHILDREN; HEALTH; SURVIVORS;
D O I
10.1016/j.spen.2022.101030
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The management of pediatric neurosurgical disease often requires families to choose between long-term disability and premature death. This decision-making is codified by informed consent. In practice, decision-making is heavily weighted toward intervening to pre-vent death, often with less consideration of the realities of long-term disability. We analyze long-term disability in pediatric neurosurgical disease from the perspectives of patients, fami-lies, and society. We then present a pragmatic framework and conversational approach for addressing informed consent discussions when the outcome is expected to be death or dis-ability. We performed a focused review of literature regarding informed consent in pediatric neurosurgery by searching PubMed and Google Scholar with search terms including "pediatric neurosurgery," "informed consent," and "disability." The literature was focused on patients with diagnoses including spina bifida, neuro-oncology, trauma, and hydrocephalus. Patient perspective elements were physical/mental disability, lack of autonomy, and role in community/society. The family perspective involves caregiver burden, emotional toll, and financial impact. Societal considerations include the availability of public resources for dis-abled children, large-scale financial cost, and impacts on global health. Practical conversa-tional steps with patients/caregivers include opening the discussion, information provision and acknowledgement of uncertainty, assessment of understanding and clarifying questions, decision-making, and decision maintenance, all while remaining sensitive to the emotional burden commensurate with these decisions. The "death or disability" paradigm represents a common challenge to informed consent in pediatric neurosurgery. Patient, family, and socie-tal factors that inform surrogate decisions vary and sometimes conflict. Pediatric neurosur-geons must use a comprehensive approach to address the informational and relational needs of caregivers during the informed consent process.Semin Pediatr Neurol 45:101030 (c) 2022 Elsevier Inc. All rights reserved.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Investigating understanding in pediatric anesthesia informed consent
    Feinstein, Max M.
    Kodish, Eric
    PEDIATRIC ANESTHESIA, 2018, 28 (06) : 565 - 566
  • [42] Informed Consent and Assent in Pediatric Oncology Trials
    Shader, Richard I.
    Livingston, Cynthia H.
    CLINICAL THERAPEUTICS, 2017, 39 (02) : 231 - 234
  • [43] Informed consent for pediatric research: Is it really possible?
    Kodish, E
    JOURNAL OF PEDIATRICS, 2003, 142 (02): : 89 - 90
  • [44] Obtaining informed consent in pediatric clinical trials
    Benkouiten, Samir
    Minodier, Philippe
    Raoult, Didier
    Brouqui, Philippe
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2014, 67 (07) : 840 - 841
  • [45] Informed consent in Pediatric Cardiology and Cardiac Surgery
    Albanese, Sonia B.
    Sellaroni, Valentina
    Montis, Sabrina
    Calcagni, Giulio
    Baban, Anwar
    Santoro, Francesco
    Pongiglione, Giacomo
    Calabro, Maria Pia
    Annecchino, Paolo
    Napoleone, Carlo Pace
    Zannini, Lucio V.
    Padalino, Massimo
    Scalzo, Gabriele
    Caianiello, Giuseppe
    Cascarano, Maria Teresa
    Colonna, Pierluigi
    Pangrazi, Alberta
    Vairo, Ugo
    Formigari, Roberto
    Donti, Andrea
    Bonvicini, Marco
    Tumbarello, Roberto
    Marasini, Maurizio
    Spadoni, Isabella
    Russo, Maria Giovanna
    Milanesi, Ornella
    Marini, Davide
    Agnoletti, Gabriella
    GIORNALE ITALIANO DI CARDIOLOGIA, 2013, 14 (09) : 613 - 621
  • [46] Immunogencity and Informed Consent in Pediatric Gene Therapy
    Shah, Lesha D.
    MOLECULAR THERAPY, 2021, 29 (04) : 366 - 366
  • [47] From informed consent to shared consent: A developing process in pediatric oncology
    Massimo, LM
    Wiley, TJ
    PSYCHO-ONCOLOGY, 2004, 13 (08) : S15 - S15
  • [48] Equitable and accessible informed healthcare consent process for people with intellectual disability: a systematic literature review
    Dunn, Manjekah
    Strnadova, Iva
    Scully, Jackie Leach
    Hansen, Jennifer
    Loblinzk, Julie
    Sarfaraz, Skie
    Molnar, Chloe
    Palmer, Elizabeth Emma
    BMJ QUALITY & SAFETY, 2024, 33 (05) : 328 - 339
  • [49] INFORMED CONSENT OR INFORMED COERCION - DECISION-MAKING IN PEDIATRIC PSYCHOPHARMACOLOGY
    KRENER, PK
    MANCINA, RA
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 1994, 4 (03) : 183 - 200
  • [50] Institutional review boards and informed consent
    Ellis, GB
    IDEA TO PRODUCT: THE PROCESS, 1996, : 141 - 146